RecruitingNCT06797752

Effect of the Stellate Ganglion Block on the Retinal Microcirculation

Effect of the Stellate Ganglion Block on the Retinal Microcirculation: A Pilot Study


Sponsor

University of Texas Southwestern Medical Center

Enrollment

50 participants

Start Date

Oct 7, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

Surges in the sympathetic nervous system occur at the ictus of a variety of neurological critical illnesses including intracranial hemorrhage and ischemic stroke. It is hypothesized that these exaggerated increases in sympathetic nervous activity produce maladaptations that promote secondary brain injury. One of these possible mechanisms include diffuse vasospasm that cause cerebral ischemia. Hence, methods to abrogate the sympathetic nervous system in this context are under active investigation. One possible method is the regional anesthesia technique of the stellate ganglion nerve block, which is ordinarily used for complex regional pain syndrome, but has been shown to reduce cerebral sympathetic activity and reduces vasospasm in patients with subarachnoid hemorrhage. However, its effect on the microcirculation is not clear. Hence, we propose to study patients receiving the stellate ganglion nerve block as part of their standard medical care and to image their retinal microcirculation before and after the procedure using Optical Coherence Tomography Angiography (OCTA).


Eligibility

Min Age: 18 Years

Inclusion Criteria2

  • Age 18 years or older
  • Patients receiving the stellate ganglion nerve block for an approved indication, e.g. complex regional pain syndrome

Exclusion Criteria3

  • Pregnancy
  • Non-English speaking
  • Temporary or permanent physical limitation that renders the patient unable to sit up and look inside OCTA device

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEOCTA Scan

Optical Coherence Tomography Angiography before and after receiving the stellate ganglion nerve block.


Locations(1)

UT Southwestern Medical Center

Dallas, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06797752


Related Trials